First, while we used a LysM-Cre system to delete S100A9 in myeloid cells, this approach does not distinguish between monocytes, macrophages, and neutrophils, limiting our ability to pinpoint the precise cellular contributors to AF pathology. This evidence concerns the gene S100A9 and atrial fibrillation.